Cite
MLA Citation
W J Sandborn et al.. “P466 Tofacitinib for the treatment of ulcerative colitis: Up to 5.4 years of safety data from global clinical trials.” Journal of Crohn's and colitis, vol. 13, n.d., p. S344. http://access.bl.uk/ark:/81055/vdc_100092361693.0x000008